Weight regain after stopping GLP-1 medications is the rule, not the exception
doi: 10.1016/j.ajhg.2017.02.005 60
Journal of Neurochemistry 128 (3): 459-71
doi: 10.3389/fmicb.2026.1787284 Received 15 January 2026 Revised 23 February 2026 Accepted 25 February 2026 Published 17 March 2026 Volume 17 - 2026 Edited by Charalampia Amerikanou, Harokopio University, Greece Reviewed by Marie-Joelle Franoise Virolle, Centre National de la Recherche Scientifique (CNRS), France Peng Li, Northwestern Polytechnical University, China Updates Copyright 2026 Niu, Wang, Lu and Yu
For GLP-1 reconstitution in Bacteriostatic Water, the DPP-IV inhibitor requirement for biological matrix applications applies regardless of reconstitution vehicle , Bacteriostatic Water itself does not contain DPP-IV activity, but any subsequent addition to biological matrices requires DPP-IV inhibitor supplementation
10.1345/aph.19242 Millington DS, Bohan TP, Roe CR, Yergey AL, Liberato DJ: Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatographymass spectrometry
